Filtered By:
Therapy: Cancer Therapy
Countries: USA Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 203 results found since Jan 2013.

A National Cancer Grid pooled procurement initiative, India
This study reveals the advantages of group negotiation in pooled procurement for high-value medicines, an approach that can be applied to other health systems.PMID:37638358 | PMC:PMC10452934 | DOI:10.2471/BLT.23.289714
Source: Bulletin of the World Health Organization - August 28, 2023 Category: International Medicine & Public Health Authors: C S Pramesh Manju Sengar Sumedha Patankar Girish Chinnaswamy Sudeep Gupta M Vijayakumar Sanjeev Sood Anil N Sathe Venkatraman Radhakrishnan Prasanth Ganesan Krishna Mohan Mallavarapu Rajendra A Badwe Source Type: research

Tumor heterogeneity: An oncogenic driver of PDAC progression and therapy resistance under stress conditions
Adv Cancer Res. 2023;159:203-249. doi: 10.1016/bs.acr.2023.02.005. Epub 2023 Apr 21.ABSTRACTPancreatic ductal adenocarcinoma (PDAC) is a clinically challenging disease usually diagnosed at advanced or metastasized stage. By this year end, there are an expected increase in 62,210 new cases and 49,830 deaths in the United States, with 90% corresponding to PDAC subtype alone. Despite advances in cancer therapy, one of the major challenges combating PDAC remains tumor heterogeneity between PDAC patients and within the primary and metastatic lesions of the same patient. This review describes the PDAC subtypes based on the genom...
Source: Advances in Cancer Research - June 2, 2023 Category: Cancer & Oncology Authors: Ant ónio M Palma Vignesh Vudatha Maria Leonor Peixoto Esha Madan Source Type: research